Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer

Efficacy of adjuvant chemotherapy stratified by age and the 21-gene recurrence score in estrogen receptor-positive breast cancer

Abstract Background The 21-gene recurrence score (RS) can predict chemotherapy benefit in estrogen receptor-positive, human epidermal growth factor receptor-2-negative (ER+/HER2-) early breast cancer patients. Age would influence the interaction between RS and chemotherapy effect. The current study...

Full description

Bibliographic Details
Main Authors: Jing Yu, Caijin Lin, Jiahui Huang, Jin Hong, Weiqi Gao, Siji Zhu, Lin Lin, Xiaosong Chen, Ou Huang, Jianrong He, Li Zhu, Weiguo Chen, Yafen Li, Jiayi Wu, Kunwei Shen
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Cancer
Subjects:
Breast cancer
21-gene recurrence score
Chemotherapy
Age
Prognosis and prediction
Online Access:https://doi.org/10.1186/s12885-021-08461-9

Internet

https://doi.org/10.1186/s12885-021-08461-9

Similar Items